TreeWAS – Variant ID: rs1610637

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	1.000	0.000	0.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
K51 Ulcerative colitis	0.000	0.000	1.000
K51.9 Ulcerative colitis, unspecified	0.000	0.000	1.000
R31 Unspecified haematuria	0.000	0.000	1.000
L40 Psoriasis	0.998	0.002	0.000
L40.5 Arthropathic psoriasis	0.996	0.004	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.023	0.977
K50-K52 Noninfective enteritis and colitis	0.000	0.023	0.977
K50 Crohn's disease [regional enteritis]	0.000	0.024	0.976
K51.8 Other ulcerative colitis	0.000	0.025	0.975
K50.9 Crohn's disease, unspecified	0.000	0.038	0.962
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.063	0.937
K51.5 Mucosal proctocolitis	0.000	0.063	0.937
K51.4 Pseudopolyposis of colon	0.000	0.089	0.911
K50.1 Crohn's disease of large intestine	0.000	0.103	0.897
K50.8 Other Crohn's disease	0.000	0.111	0.889
L40.0 Psoriasis vulgaris	0.866	0.134	0.000
L40.3 Pustulosis palmaris et plantaris	0.791	0.209	0.000
L40.1 Generalised pustular psoriasis	0.790	0.210	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.240	0.760
E83.1 Disorders of iron metabolism	0.000	0.256	0.744
K50.0 Crohn's disease of small intestine	0.000	0.273	0.727
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.283	0.717
L40.4 Guttate psoriasis	0.715	0.285	0.000
L40.2 Acrodermatitis continua	0.715	0.285	0.000
L40.8 Other psoriasis	0.613	0.387	0.000
K90 Intestinal malabsorption	0.603	0.397	0.000
R30-R39 Symptoms and signs involving the urinary system	0.000	0.445	0.555
R39 Other symptoms and signs involving the urinary system	0.000	0.445	0.555
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.000	0.446	0.554
K90.8 Other intestinal malabsorption	0.487	0.513	0.000
R39.1 Other difficulties with micturition	0.000	0.520	0.480
K90.9 Intestinal malabsorption, unspecified	0.471	0.529	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.462	0.538	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.434	0.566	0.000
K90.3 Pancreatic steatorrhoea	0.432	0.568	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.432	0.568	0.000
K90.1 Tropical sprue	0.432	0.568	0.000
R30 Pain associated with micturition	0.000	0.586	0.414
R39.2 Extrarenal uraemia	0.000	0.602	0.398
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.378	0.622	0.000
R36 Urethral discharge	0.000	0.623	0.376
K62.8 Other specified diseases of anus and rectum	0.000	0.634	0.366
R30.0 Dysuria	0.000	0.641	0.359
R39.0 Extravasation of urine	0.000	0.655	0.344
C85.1 B-cell lymphoma, unspecified	0.328	0.672	0.000
R30.1 Vesical tenesmus	0.000	0.679	0.321
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.310	0.690	0.000
R35 Polyuria	0.000	0.700	0.300
C85.7 Other specified types of non-Hodgkin's lymphoma	0.288	0.712	0.000
C85.0 Lymphosarcoma	0.271	0.728	0.000
R34 Anuria and oliguria	0.000	0.749	0.251
L40-L45 Papulosquamous disorders	0.230	0.770	0.000
R33 Retention of urine	0.000	0.791	0.209
N13 Obstructive and reflux uropathy	0.180	0.820	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.177	0.823	0.000
K52 Other non-infective gastro-enteritis and colitis	0.000	0.825	0.175
N13.5 Kinking and stricture of ureter without hydronephrosis	0.175	0.825	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.171	0.829	0.000
L44 Other papulosquamous disorders	0.165	0.835	0.000
L41 Parapsoriasis	0.165	0.835	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.165	0.835	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.161	0.839	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.000	0.846	0.154
R30.9 Painful micturition, unspecified	0.000	0.851	0.148
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.146	0.854	0.000
N13.6 Pyonephrosis	0.146	0.854	0.000
N13.4 Hydroureter	0.143	0.856	0.000
L42 Pityriasis rosea	0.142	0.858	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.141	0.859	0.000
C81 Hodgkin's disease	0.141	0.859	0.000
C81.9 Hodgkin's disease, unspecified	0.134	0.866	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.134	0.866	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.125	0.875	0.000
N10-N16 Renal tubulo-interstitial diseases	0.124	0.876	0.000
C84.5 Other and unspecified T-cell lymphomas	0.124	0.876	0.000
N11 Chronic tubulo-interstitial nephritis	0.122	0.878	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.000	0.881	0.119
L41.9 Parapsoriasis, unspecified	0.118	0.881	0.000
L41.8 Other parapsoriasis	0.118	0.881	0.000
L41.5 Retiform parapsoriasis	0.118	0.881	0.000
L41.4 Large plaque parapsoriasis	0.118	0.881	0.000
L41.3 Small plaque parapsoriasis	0.118	0.881	0.000
L41.2 Lymphomatoid papulosis	0.118	0.881	0.000
L41.1 Pityriasis lichenoides chronica	0.118	0.881	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.118	0.881	0.000
L44.9 Papulosquamous disorder, unspecified	0.118	0.881	0.000
L44.8 Other specified papulosquamous disorders	0.118	0.881	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.118	0.881	0.000
L44.3 Lichen ruber moniliformis	0.118	0.881	0.000
L44.2 Lichen striatus	0.118	0.881	0.000
L44.1 Lichen nitidus	0.118	0.881	0.000
L44.0 Pityriasis rubra pilaris	0.118	0.881	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.116	0.884	0.000
K52.1 Toxic gastro-enteritis and colitis	0.000	0.884	0.115
C81.1 Nodular sclerosis	0.115	0.885	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.115	0.885	0.000
C81.2 Mixed cellularity	0.112	0.888	0.000
C95 Leukaemia of unspecified cell type	0.111	0.889	0.000
C83.3 Large cell (diffuse)	0.110	0.890	0.000
C93 Monocytic leukaemia	0.109	0.891	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.105	0.895	0.000
C94 Other leukaemias of specified cell type	0.105	0.895	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.104	0.896	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.104	0.896	0.000
C88 Malignant immunoproliferative diseases	0.102	0.898	0.000
N11.1 Chronic obstructive pyelonephritis	0.102	0.898	0.000
C81.7 Other Hodgkin's disease	0.101	0.899	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.101	0.899	0.000
C81.3 Lymphocytic depletion	0.101	0.899	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.100	0.900	0.000
L43 Lichen planus	0.097	0.902	0.000
C86 Other specified types of T/NK-cell lymphoma	0.097	0.902	0.000
C84.4 Peripheral T-cell lymphoma	0.097	0.903	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.096	0.904	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.096	0.904	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.096	0.904	0.000
C84.3 Lymphoepithelioid lymphoma	0.096	0.904	0.000
C84.2 T-zone lymphoma	0.096	0.904	0.000
C84.1 Sezary's diease	0.096	0.904	0.000
K52.3 Indeterminate colitis	0.000	0.907	0.092
C84.0 Mycosis fungoides	0.091	0.909	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.089	0.911	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.088	0.912	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.087	0.913	0.000
C81.0 Lymphocytic predominance	0.085	0.915	0.000
C83.1 Small cleaved cell (diffuse)	0.085	0.915	0.000
C83.6 Undifferentiated (diffuse)	0.083	0.917	0.000
C83.5 Lymphoblastic (diffuse)	0.083	0.917	0.000
C83.4 Immunoblastic (diffuse)	0.083	0.917	0.000
C83.2 Mixed small and large cell (diffuse)	0.083	0.917	0.000
N15 Other renal tubulo-interstitial diseases	0.083	0.917	0.000
N13.8 Other obstructive and reflux uropathy	0.083	0.917	0.000
C83.7 Burkitt's tumour	0.082	0.917	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.082	0.918	0.000
C93.1 Chronic monocytic leukaemia	0.082	0.918	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.082	0.918	0.000
C95.7 Other leukaemia of unspecified cell type	0.080	0.920	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.080	0.920	0.000
C95.0 Acute leukaemia of unspecified cell type	0.080	0.920	0.000
C95.9 Leukaemia, unspecified	0.078	0.921	0.000
C93.9 Monocytic leukaemia, unspecified	0.078	0.922	0.000
C93.7 Other monocytic leukaemia	0.078	0.922	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.078	0.922	0.000
C93.2 Subacute monocytic leukaemia	0.078	0.922	0.000
C93.0 Acute monocytic leukaemia	0.078	0.922	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.078	0.922	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.076	0.924	0.000
C94.7 Other specified leukaemias	0.075	0.924	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.075	0.924	0.000
C94.5 Acute myelofibrosis	0.075	0.924	0.000
C94.4 Acute panmyelosis	0.075	0.924	0.000
C94.3 Mast cell leukaemia	0.075	0.924	0.000
C94.2 Acute megakaryoblastic leukaemia	0.075	0.924	0.000
C94.1 Chronic erythraemia	0.075	0.924	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.075	0.924	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.075	0.924	0.000
C96.8 Histiocytic sarcoma	0.075	0.924	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.075	0.924	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.075	0.924	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.075	0.924	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.075	0.924	0.000
C96.3 True histiocytic lymphoma	0.075	0.924	0.000
C96.2 Malignant mast cell tumour	0.075	0.924	0.000
C96.1 Malignant histiocytosis	0.075	0.924	0.000
C96.0 Letterer-Siwe disease	0.075	0.924	0.000
N10 Acute tubulo-interstitial nephritis	0.075	0.925	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.074	0.926	0.000
C88.7 Other malignant immunoproliferative diseases	0.074	0.926	0.000
C88.3 Immunoproliferative small intestinal disease	0.074	0.926	0.000
C88.2 Gamma heavy chain disease	0.074	0.926	0.000
C88.1 Alpha heavy chain disease	0.074	0.926	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.072	0.928	0.000
N14.3 Nephropathy induced by heavy metals	0.072	0.928	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.072	0.928	0.000
N14.0 Analgesic nephropathy	0.072	0.928	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.071	0.929	0.000
L43.3 Subacute (active) lichen planus	0.070	0.930	0.000
L43.2 Lichenoid drug reaction	0.070	0.930	0.000
L43.1 Bullous lichen planus	0.070	0.930	0.000
L43.0 Hypertrophic lichen planus	0.070	0.930	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.070	0.930	0.000
C86.4 Blastic NK-cell lymphoma	0.070	0.930	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.070	0.930	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.070	0.930	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.070	0.930	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.070	0.930	0.000
C83.0 Small cell (diffuse)	0.070	0.930	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.065	0.934	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.064	0.936	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.064	0.936	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.064	0.936	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.064	0.936	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.064	0.936	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.064	0.936	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.064	0.936	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.064	0.936	0.000
L43.8 Other lichen planus	0.064	0.936	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.063	0.937	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.062	0.937	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.060	0.940	0.000
N15.0 Balkan nephropathy	0.060	0.940	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.059	0.941	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.058	0.942	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.942	0.058
E05.9 Thyrotoxicosis, unspecified	0.058	0.942	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.057	0.943	0.000
N15.1 Renal and perinephric abscess	0.056	0.944	0.000
K90-K93 Other diseases of the digestive system	0.055	0.945	0.000
C90.2 Plasmacytoma, extramedullary	0.054	0.946	0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.948	0.052
C91 Lymphoid leukaemia	0.051	0.949	0.000
K40 Inguinal hernia	0.000	0.950	0.050
G56.0 Carpal tunnel syndrome	0.050	0.950	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.048	0.951	0.000
C90.1 Plasma cell leukaemia	0.048	0.952	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.045	0.955	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.045	0.955	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.045	0.955	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.045	0.955	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.045	0.955	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.045	0.955	0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.045	0.955	0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.045	0.955	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.045	0.955	0.000
E83 Disorders of mineral metabolism	0.000	0.956	0.044
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.043	0.957	0.000
E05.8 Other thyrotoxicosis	0.042	0.957	0.000
E05.5 Thyroid crisis or storm	0.042	0.958	0.000
E05.4 Thyrotoxicosis factitia	0.042	0.958	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.042	0.958	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.042	0.958	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.039	0.960	0.000
E10.3 With ophthalmic complications	0.039	0.961	0.000
C90.3 Solitary plasmacytoma	0.039	0.961	0.000
C90.0 Multiple myeloma	0.037	0.963	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.036	0.963	0.000
C91.7 Other lymphoid leukaemia	0.036	0.963	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.036	0.963	0.000
C91.3 Prolymphocytic leukaemia	0.036	0.963	0.000
C91.2 Subacute lymphocytic leukaemia	0.036	0.963	0.000
C91.9 Lymphoid leukaemia, unspecified	0.036	0.963	0.000
K40.1 Bilateral inguinal hernia, with gangrene	0.000	0.964	0.036
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.000	0.964	0.036
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene	0.000	0.964	0.036
E10.2 With renal complications	0.036	0.964	0.000
E10 Insulin-dependent diabetes mellitus	0.036	0.964	0.000
C82.2 Large cell, follicular	0.035	0.965	0.000
C91.5 Adult T-cell leukaemia	0.035	0.965	0.000
C82.0 Small cleaved cell, follicular	0.032	0.968	0.000
E83.8 Other disorders of mineral metabolism	0.000	0.968	0.031
E83.2 Disorders of zinc metabolism	0.000	0.968	0.031
E83.0 Disorders of copper metabolism	0.000	0.968	0.031
R32 Unspecified urinary incontinence	0.000	0.968	0.032
C82.6 Cutaneous follicle centre lymphoma	0.031	0.969	0.000
C82.5 Diffuse follicle centre lymphoma	0.031	0.969	0.000
C82.4 Follicular lymphoma grade IIIb	0.031	0.969	0.000
C91.4 Hairy-cell leukaemia	0.030	0.969	0.000
C91.0 Acute lymphoblastic leukaemia	0.030	0.970	0.000
L94 Other localised connective tissue disorders	0.030	0.970	0.000
B02.9 Zoster without complication	0.029	0.971	0.000
E10.9 Without complications	0.029	0.971	0.000
E10-E14 Diabetes mellitus	0.029	0.971	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.029	0.971	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.028	0.971	0.000
K93.1 Megacolon in Chagas' disease	0.028	0.971	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.028	0.971	0.000
L94.0 Localised scleroderma [morphea]	0.029	0.971	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.028	0.972	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.001	0.972	0.028
L89 Decubitus ulcer	0.028	0.972	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.028	0.972	0.000
C92 Myeloid leukaemia	0.027	0.972	0.000
E10.1 With ketoacidosis	0.027	0.973	0.000
L93 Lupus erythematosus	0.026	0.974	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.026	0.974	0.000
L81 Other disorders of pigmentation	0.026	0.974	0.000
E10.7 With multiple complications	0.025	0.975	0.000
L94.2 Calcinosis cutis	0.025	0.975	0.000
L93.0 Discoid lupus erythematosus	0.025	0.975	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.025	0.975	0.000
M72 Fibroblastic disorders	0.025	0.975	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.025	0.975	0.000
E83.3 Disorders of phosphorus metabolism	0.000	0.976	0.024
L95 Vasculitis limited to skin, not elsewhere classified	0.024	0.976	0.000
E10.4 With neurological complications	0.024	0.976	0.000
C82.3 Follicular lymphoma grade IIIa	0.024	0.976	0.000
L89.2 Stage III decubitus ulcer	0.024	0.976	0.000
E13 Other specified diabetes mellitus	0.024	0.976	0.000
L10-L14 Bullous disorders	0.024	0.976	0.000
L81.8 Other specified disorders of pigmentation	0.023	0.976	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.023	0.977	0.000
E14 Unspecified diabetes mellitus	0.023	0.977	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.977	0.023
L94.8 Other specified localised connective tissue disorders	0.023	0.977	0.000
L94.9 Localised connective tissue disorder, unspecified	0.023	0.977	0.000
E10.6 With other specified complications	0.022	0.978	0.000
E10.8 With unspecified complications	0.022	0.978	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.022	0.978	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.022	0.978	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.022	0.978	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.978	0.021
L80 Vitiligo	0.021	0.979	0.000
L94.6 Ainhum	0.021	0.979	0.000
L94.5 Poikiloderma vasculare atrophicans	0.021	0.979	0.000
L94.4 Gottron's papules	0.021	0.979	0.000
L94.3 Sclerodactyly	0.021	0.979	0.000
L94.1 Linear scleroderma	0.021	0.979	0.000
L92.0 Granuloma annulare	0.021	0.979	0.000
L81.9 Disorder of pigmentation, unspecified	0.021	0.979	0.000
E12 Malnutrition-related diabetes mellitus	0.021	0.979	0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.021	0.979	0.000
L87 Transepidermal elimination disorders	0.021	0.979	0.000
L86 Keratoderma in diseases classified elsewhere	0.021	0.979	0.000
L43.9 Lichen planus, unspecified	0.020	0.979	0.000
L81.2 Freckles	0.020	0.979	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.020	0.979	0.000
C91.1 Chronic lymphocytic leukaemia	0.020	0.980	0.000
L13 Other bullous disorders	0.020	0.980	0.000
E14.5 With peripheral circulatory complications	0.020	0.980	0.000
E10.0 With coma	0.020	0.980	0.000
E00-E07 Disorders of thyroid gland	0.020	0.980	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.020	0.980	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.020	0.980	0.000
C92.5 Acute myelomonocytic leukaemia	0.020	0.980	0.000
C92.3 Myeloid sarcoma	0.020	0.980	0.000
C92.2 Subacute myeloid leukaemia	0.020	0.980	0.000
C92.9 Myeloid leukaemia, unspecified	0.020	0.980	0.000
L95.8 Other vasculitis limited to skin	0.020	0.980	0.000
E13.3 With ophthalmic complications	0.020	0.980	0.000
E14.1 With ketoacidosis	0.019	0.980	0.000
E10.5 With peripheral circulatory complications	0.019	0.980	0.000
L81.4 Other melanin hyperpigmentation	0.019	0.981	0.000
E50-E64 Other nutritional deficiencies	0.019	0.981	0.000
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.019	0.981	0.000
E55.9 Vitamin D deficiency, unspecified	0.019	0.981	0.000
L95.9 Vasculitis limited to skin, unspecified	0.019	0.981	0.000
L93.2 Other local lupus erythematosus	0.019	0.981	0.000
L93.1 Subacute cutaneous lupus erythematosus	0.019	0.981	0.000
L81.7 Pigmented purpuric dermatosis	0.019	0.981	0.000
L81.6 Other disorders of diminished melanin formation	0.019	0.981	0.000
L81.5 Leukoderma, not elsewhere classified	0.019	0.981	0.000
L81.3 Cafe au lait spots	0.019	0.981	0.000
L81.1 Chloasma	0.019	0.981	0.000
L81.0 Postinflammatory hyperpigmentation	0.019	0.981	0.000
E55 Vitamin D deficiency	0.019	0.981	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.019	0.981	0.000
L50-L54 Urticaria and erythema	0.019	0.981	0.000
E11 Non-insulin-dependent diabetes mellitus	0.019	0.981	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.019	0.981	0.000
M72.2 Plantar fascial fibromatosis	0.018	0.981	0.000
E13.9 Without complications	0.018	0.982	0.000
L88 Pyoderma gangrenosum	0.018	0.982	0.000
C92.7 Other myeloid leukaemia	0.018	0.982	0.000
M72.9 Fibroblastic disorder, unspecified	0.018	0.982	0.000
M72.8 Other fibroblastic disorders	0.018	0.982	0.000
M72.6 Necrotizing fasciitis	0.018	0.982	0.000
M72.5 Fasciitis, not elsewhere classified	0.018	0.982	0.000
M72.4 Pseudosarcomatous fibromatosis	0.018	0.982	0.000
M72.3 Nodular fasciitis	0.018	0.982	0.000
L91 Hypertrophic disorders of skin	0.018	0.982	0.000
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.018	0.982	0.000
L13.0 Dermatitis herpetiformis	0.018	0.982	0.000
L12 Pemphigoid	0.018	0.982	0.000
E14.4 With neurological complications	0.018	0.982	0.000
K91.5 Postcholecystectomy syndrome	0.018	0.982	0.000
L95.1 Erythema elevatum diutinum	0.017	0.982	0.000
L95.0 Livedoid vasculitis	0.017	0.982	0.000
L11 Other acantholytic disorders	0.017	0.982	0.000
E13.8 With unspecified complications	0.017	0.983	0.000
E13.7 With multiple complications	0.017	0.983	0.000
E13.6 With other specified complications	0.017	0.983	0.000
E13.5 With peripheral circulatory complications	0.017	0.983	0.000
E13.4 With neurological complications	0.017	0.983	0.000
E13.2 With renal complications	0.017	0.983	0.000
E13.1 With ketoacidosis	0.017	0.983	0.000
E13.0 With coma	0.017	0.983	0.000
L10 Pemphigus	0.017	0.983	0.000
L14 Bullous disorders in diseases classified elsewhere	0.017	0.983	0.000
E14.8 With unspecified complications	0.017	0.983	0.000
E61 Deficiency of other nutrient elements	0.017	0.983	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.017	0.983	0.000
E14.7 With multiple complications	0.017	0.983	0.000
E14.0 With coma	0.017	0.983	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.017	0.983	0.000
B02 Zoster [herpes zoster]	0.017	0.983	0.000
E14.9 Without complications	0.017	0.983	0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.016	0.983	0.000
K91.1 Postgastric surgery syndromes	0.016	0.983	0.000
E11.7 With multiple complications	0.016	0.984	0.000
E14.2 Withrenal complications	0.016	0.984	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.016	0.984	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.016	0.984	0.000
M07.3 Other psoriatic arthropathies	0.016	0.984	0.000
C92.4 Acute promyelocytic leukaemia	0.015	0.984	0.001
E11.9 Without complications	0.016	0.984	0.000
L91.0 Keloid scar	0.016	0.984	0.000
M72.1 Knuckle pads	0.016	0.984	0.000
L83 Acanthosis nigricans	0.015	0.984	0.000
E11.5 With peripheral circulatory complications	0.016	0.984	0.000
N13.3 Other and unspecified hydronephrosis	0.015	0.985	0.000
L50 Urticaria	0.015	0.985	0.000
E12.9 Without complications	0.015	0.985	0.000
E12.8 With unspecified complications	0.015	0.985	0.000
E12.7 With multiple complications	0.015	0.985	0.000
E12.6 With other specified complications	0.015	0.985	0.000
E12.5 With peripheral circulatory complications	0.015	0.985	0.000
E12.4 With neurological complications	0.015	0.985	0.000
E12.3 With ophthalmic complications	0.015	0.985	0.000
E12.2 With renal complications	0.015	0.985	0.000
E12.1 With ketoacidosis	0.015	0.985	0.000
E12.0 With coma	0.015	0.985	0.000
L87.9 Transepidermal elimination disorder, unspecified	0.015	0.985	0.000
L87.8 Other transepidermal elimination disorders	0.015	0.985	0.000
L87.2 Elastosis perforans serpiginosa	0.015	0.985	0.000
L87.1 Reactive perforating collagenosis	0.015	0.985	0.000
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.015	0.985	0.000
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.015	0.985	0.000
L99.0 Amyloidosis of skin	0.015	0.985	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.015	0.985	0.000
E14.6 With other specified complications	0.015	0.985	0.000
E61.1 Iron deficiency	0.015	0.985	0.000
L13.9 Bullous disorder, unspecified	0.015	0.985	0.000
L13.8 Other specified bullous disorders	0.015	0.985	0.000
L13.1 Subcorneal pustular dermatitis	0.015	0.985	0.000
E11.2 With renal complications	0.015	0.985	0.000
L89.3 Stage IV decubitus ulcer	0.015	0.985	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.015	0.985	0.000
E00 Congenital iodine-deficiency syndrome	0.015	0.985	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.015	0.985	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.015	0.985	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.014	0.986	0.000
E51 Thiamine deficiency	0.014	0.986	0.000
E58 Dietary calcium deficiency	0.014	0.986	0.000
E11.1 With ketoacidosis	0.014	0.986	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.014	0.986	0.000
E63 Other nutritional deficiencies	0.014	0.986	0.000
E50 Vitamin A deficiency	0.014	0.986	0.000
E60 Dietary zinc deficiency	0.014	0.986	0.000
E59 Dietary selenium deficiency	0.014	0.986	0.000
E54 Ascorbic acid deficiency	0.014	0.986	0.000
E52 Niacin deficiency [pellagra]	0.014	0.986	0.000
L52 Erythema nodosum	0.014	0.986	0.000
E55.0 Rickets, active	0.014	0.986	0.000
L12.1 Cicatricial pemphigoid	0.014	0.986	0.000
L54 Erythema in diseases classified elsewhere	0.014	0.986	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.014	0.986	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.014	0.986	0.000
E53 Deficiency of other B group vitamins	0.014	0.986	0.000
E11.6 With other specified complications	0.014	0.986	0.000
E61.2 Magnesium deficiency	0.014	0.986	0.000
E56 Other vitamin deficiencies	0.013	0.986	0.000
M72.28 Plantar fascial fibromatosis-Other	0.013	0.986	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.013	0.986	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.013	0.986	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.013	0.986	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.013	0.986	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.013	0.986	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.013	0.986	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.013	0.986	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.013	0.986	0.000
L12.9 Pemphigoid, unspecified	0.013	0.986	0.000
M07.38 Other psoriatic arthropathies (Other)	0.013	0.987	0.000
E11.8 With unspecified complications	0.013	0.987	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.002	0.987	0.011
M72.39 Nodular fasciitis-Site unspec	0.013	0.987	0.000
M72.38 Nodular fasciitis-Other	0.013	0.987	0.000
M72.37 Nodular fasciitis-Ankle/Foot	0.013	0.987	0.000
M72.36 Nodular fasciitis-Lower Leg	0.013	0.987	0.000
M72.35 Nodular fasciitis-Pelvic/Thigh	0.013	0.987	0.000
M72.34 Nodular fasciitis-Hand	0.013	0.987	0.000
M72.33 Nodular fasciitis-Forearm	0.013	0.987	0.000
M72.32 Nodular fasciitis-Upper arm	0.013	0.987	0.000
M72.31 Nodular fasciitis-Shldr region	0.013	0.987	0.000
M72.30 Nodular fasciitis-Mult sites	0.013	0.987	0.000
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.013	0.987	0.000
M72.48 Pseudosarcomatous fibromatosis (Other)	0.013	0.987	0.000
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.013	0.987	0.000
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.013	0.987	0.000
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.013	0.987	0.000
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.013	0.987	0.000
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.013	0.987	0.000
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.013	0.987	0.000
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.013	0.987	0.000
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.013	0.987	0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.013	0.987	0.000
M72.58 Fasciitis, not elsewhere classified-Other	0.013	0.987	0.000
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.013	0.987	0.000
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.013	0.987	0.000
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.013	0.987	0.000
M72.54 Fasciitis, not elsewhere classified-Hand	0.013	0.987	0.000
M72.53 Fasciitis, not elsewhere classified-Forearm	0.013	0.987	0.000
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.013	0.987	0.000
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.013	0.987	0.000
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.013	0.987	0.000
M72.69 Necrotizing fasciitis (Site unspecified)	0.013	0.987	0.000
M72.68 Necrotizing fasciitis (Other)	0.013	0.987	0.000
M72.67 Necrotizing fasciitis (Ankle and foot)	0.013	0.987	0.000
M72.66 Necrotizing fasciitis (Lower leg)	0.013	0.987	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations